Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/MJ BIOTECH, INC./ 8-K

Current Report · 8-K

MJ BIOTECH, INC.

Current Report

Filed May 20, 2019Accepted May 20, 2019, 10:11 AM EDTCIK 1543272Accession 0001543272-19-000021
View company →Permanent SEC source ↗
Share

Company context

Historical securities (1)
MJTVNASDAQ · EQUITY · Historical · closed Sep 3, 2021

Recent company filings

  1. REVOKED filingDec 23, 2025
  2. REVOKED filingSep 7, 2021
  3. 8-K filingAug 18, 2021
  4. 8-K filingJan 12, 2021
  5. NT 10-Q filingAug 14, 2019

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗